Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute inflammation.
Cuzzocrea S, Pisano B, Dugo L, Ianaro A, Maffia P, Patel NS, Di Paola R, Ialenti A, Genovese T, Chatterjee PK, Di Rosa M, Caputi AP, Thiemermann C.
Cuzzocrea S, et al. Among authors: maffia p.
Eur J Pharmacol. 2004 Jan 1;483(1):79-93. doi: 10.1016/j.ejphar.2003.10.056.
Eur J Pharmacol. 2004.
PMID: 14709329
Retracted.